Log in to save to my catalogue

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai scho...

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai scho...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1257747193

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

About this item

Full title

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Publisher

Kidlington: Elsevier Ltd

Journal title

The Lancet (British edition), 2012-11, Vol.380 (9853), p.1559-1567

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Roughly half the world's population live in dengue-endemic countries, but no vaccine is licensed. We investigated the efficacy of a recombinant, live, attenuated tetravalent dengue vaccine. Methods In this observer-masked, randomised, controlled, monocentre, phase 2b, proof-of-concept trial, healthy Thai schoolchildren aged 4–11...

Alternative Titles

Full title

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1257747193

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1257747193

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(12)61428-7

How to access this item